BRASILIA (REUTERS) - Brazil's health regulator Anvisa on Tuesday (Aug 18) said it had approved human clinical trials for a potential Covid-19 vaccine developed by Johnson & Johnson's pharmaceutical subsidiary Janssen.. Read more at straitstimes.com.
BRASILIA - Brazil's health regulator Anvisa on Tuesday said it had approved human clinical trials for a potential Covid-19 vaccine developed by Johnson & Johnson's pharmaceutical subsidiary Janssen.
Brazil had registered 3.4 million cases of the disease and more than 108,000 related deaths as of Monday.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Brazil approves human trials for potential Johnson & Johnson COVID-19 vaccineBRASILIA: Brazil's health regulator Anvisa on Tuesday (Aug 18) said it has approved stage 3 clinical trials for a potential COVID-19 vaccine ...
Read more »
Brazil indigenous protesters demand help against COVID-19Brandishing bows and arrows, dozens of indigenous protesters blocked a main highway through the Brazilian Amazon Monday, demanding help against ...
Read more »
Brazil approves human trials for potential Johnson & Johnson COVID-19 vaccineBRASILIA: Brazil's health regulator Anvisa on Tuesday (Aug 18) said it has approved stage 3 clinical trials for a potential COVID-19 vaccine ...
Read more »
Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trialPakistan's drug regulator greenlit the country's first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by ...
Read more »
Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trialPakistan's drug regulator greenlit the country's first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by China's CanSino Biologics (CanSino) and Beijing Institute of Biotechnology. Government-run National Institute of Health (NIH) will be leading the trial
Read more »
Britain encourages at-risk groups to sign up for Covid-19 vaccine trialsLONDON (REUTERS) - Britain on Monday (Aug 17) urged elderly people and volunteers from Black and Asian minority groups to sign up to a Covid-19 vaccine trial registry to boost efforts to find a working vaccine against the disease that offers protection against higher risk groups.. Read more at straitstimes.com.
Read more »